Toll Free: 1-888-928-9744
Published: Jun, 2014 | Pages:
28 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Senhwa Biosciences, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Senhwa Biosciences - Product Pipeline Review - 2014', provides an overview of the Senhwa Biosciences's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Senhwa Biosciences's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Senhwa Biosciences including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Senhwa Biosciences's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Senhwa Biosciences's pipeline products Reasons to buy - Evaluate Senhwa Biosciences's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Senhwa Biosciences in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Senhwa Biosciences's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Senhwa Biosciences and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Senhwa Biosciences - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Senhwa Biosciences and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Senhwa Biosciences, Inc. Snapshot 4 Senhwa Biosciences, Inc. Overview 4 Key Information 4 Key Facts 4 Senhwa Biosciences, Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Senhwa Biosciences, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Senhwa Biosciences, Inc. - Pipeline Products Glance 10 Senhwa Biosciences, Inc. - Clinical Stage Pipeline Products 10 Phase I Products/Combination Treatment Modalities 10 Senhwa Biosciences, Inc. - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 Senhwa Biosciences, Inc. - Drug Profiles 12 silmitasertib 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 CX-5461 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 CK2 Inhibitor Program 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 P53/RNA Polymerase I Program 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Senhwa Biosciences, Inc. - Pipeline Analysis 18 Senhwa Biosciences, Inc. - Pipeline Products by Target 18 Senhwa Biosciences, Inc. - Pipeline Products by Route of Administration 19 Senhwa Biosciences, Inc. - Pipeline Products by Molecule Type 20 Senhwa Biosciences, Inc. - Pipeline Products by Mechanism of Action 21 Senhwa Biosciences, Inc. - Recent Pipeline Updates 22 Senhwa Biosciences, Inc. - Dormant Projects 25 Senhwa Biosciences, Inc. - Locations And Subsidiaries 26 Head Office 26 Other Locations & Subsidiaries 26 Appendix 27 Methodology 27 Coverage 27 Secondary Research 27 Primary Research 27 Expert Panel Validation 27 Contact Us 28 Disclaimer 28
List of Tables Senhwa Biosciences, Inc., Key Information 4 Senhwa Biosciences, Inc., Key Facts 4 Senhwa Biosciences, Inc. - Pipeline by Indication, 2014 7 Senhwa Biosciences, Inc. - Pipeline by Stage of Development, 2014 8 Senhwa Biosciences, Inc. - Monotherapy Products in Pipeline, 2014 9 Senhwa Biosciences, Inc. - Phase I, 2014 10 Senhwa Biosciences, Inc. - Preclinical, 2014 11 Senhwa Biosciences, Inc. - Pipeline by Target, 2014 18 Senhwa Biosciences, Inc. - Pipeline by Route of Administration, 2014 19 Senhwa Biosciences, Inc. - Pipeline by Molecule Type, 2014 20 Senhwa Biosciences, Inc. - Pipeline Products by Mechanism of Action, 2014 21 Senhwa Biosciences, Inc. - Recent Pipeline Updates, 2014 22 Senhwa Biosciences, Inc. - Dormant Developmental Projects,2014 25 Senhwa Biosciences, Inc., Other Locations 26
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.